<DOC>
	<DOCNO>NCT01942148</DOCNO>
	<brief_summary>The objective study investigate safety efficacy aripiprazole ( initial dose 2 mg/day , maintenance dose 6-24 mg/day , maximum dose 30 mg/day ) orally administer period 52 week subject complete short-term treatment study pediatric patient ( age 13-17 year ) schizophrenia ( 031-09-003 study ) .</brief_summary>
	<brief_title>A Long-term , Extended Treatment Study Aripiprazole Pediatric Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Patients diagnosis schizophrenia ( 295.30 , 295.10 , 295.20 , 295.90 , 295.60 ) , accord DSMIVTR Male female patient age 1317 year Patients complete 03109003 study Patients , addition legal guardian , provide write informed consent , understood detail study Inpatient outpatient status Patients diagnosis disease except schizophrenia , accord DSMIVTR Patients compulsorily admit hospital Patients mental retardation Patients thyroid disorder Patients fall contraindication list ABILIFY package insert Patients serious hepatic , renal , cardiac hematopoietic disorder Patients history complication organic brain disorder convulsive disorder epilepsy Patients history complication diabetes patient fall follow : fast blood glucose level ≧ 126 mg/dL , nonfasting blood glucose level ≧ 200 mg/dL , HbA1c ≧ 6.5 % Patients history complication suicide attempt , suicidal think selfharm Patients score ≧2 ( mild ) PART1 evaluation CGISS Patients history complication malignant syndrome , tardive dyskinesia paralytic ileus Patients state physical exhaustion accompany condition dehydration malnutrition Patients history complication water intoxication Patients Parkinson 's disease Pregnant woman , parturient woman , nurse woman , woman childbearing potential wish become pregnant trial . However , woman childbearing potential practicing appropriate method contraception ( refer 8.6 ) negative pregnancy test result eligible inclusion study . Study enrollment otherwise judged inappropriate Investigator Subinvestigator</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Schizophrenia , Pediatric patient</keyword>
</DOC>